INTRODUCTION
in Kawasaki Disease.
MATERIALS AND METHODS
Study design-cross-sectional study to look for echocardiographic abnormality in complete and incomplete Kawasaki Exclusion criteria-congenital heart disease patients Study tools-echocardiographic assessment was done in our cardiology department Data analysis-data were entered in Microsoft excel spread sheet and were analyzed.
RESULTS

Out of 150
Kawasaki disease patients, 129 were complete Kawasaki disease and 21 had incomplete presentations. Of them 54% (81 of 150) children were between one to five years of age ,23% (35 of 150) were between five to eight years of age and 22% children were from extremes of ages. Of them 15% (22 of 150) were infants and 7% (11 of 150) were more than eight years of age. . Out of 150 children 85(56%) were boys and 65(43%) were girls with male: female ratio being 1.3:1. In our study 14% (21 out of 150) patients presented with clinical features suggestive of incomplete Kawasaki disease. Age-wise distribution reveals 40% (9 out of 22 infants) had incomplete features while 36% (four out of 11) more than eight years of age had incomplete Kawasaki disease. In the 1-5 year age group and five to eight year of age, number of incomplete Kawasaki were 5% (four of 81) and 11% (four of 35) respectively. In our study, 28 (18.6%) patients had coronary involvement, of those 18(12%) of 150 patients were affected with coronary aneurysm, while 10 (6.6%) had perivascular brightness of coronaries. Mitral regurgitation was found in eight patients , which consists of 5% of our subjects. In our study, we found six patients (4%) had both aortic regurgitation and aortic root dilatation. We found that 45 out of 150 patients (30%) had myocarditis. The significant findings were global hypokinesia (LV Systolic dysfunction) with decreased ejection fraction. We found pericardial effusion in significant number of patients; 18 out of 150 (12%), though majority of them had mild effusion.
DISCUSSION
Kawasaki disease has been reported in all racial and ethnic groups, as well as across the entire paediatric age range, although in most cases 85% of the patients are younger than five years old. 5 In our study 54% of children were between one to five years of age, 23% were between five to eight years of age and 22% children were from extremes of ages. In various studies the peak incidence of KD was between one to two years of age. 3 Patients younger than six months or older than eight years are encountered infrequently but may be at risk of having coronary artery aneurysms. 5, 6 The lowincidence in the first six months suggests that most infants are protected by acquired maternal antibodies. 7 Senzaki H et al 10 found male patients outnumber female patients (male/female ratio: 1.2 to 1.7). We also found the similar trend girls with male: female ratio being 1.3:1. Incomplete or atypical Kawasaki disease refers to patients who do not fulfil the classic criteria of at least four of the five findings. 8 In our study 14% (21 out of 150) patients presented with clinical features suggestive of incomplete Kawasaki disease which is comparable with study by Yu JJ et al 9 where prevalence of incomplete presentation was 15% to 36.2% among patients with Kawasaki disease and relatively more children with incomplete presentation reported were in the extremes of the age spectrum (≤1 year old, or ≥5 to nine years old). In our study also 76% of atypical Kawasaki were of extremes of ages. It is also broadly agreed that KD can be diagnosed in the absence of full criteria when coronary abnormalities Original Research Article are present. 9 Cardiac involvement is the most important manifestation of Kawasaki disease (KD). Up to 25% of untreated children will develop permanent damage to the coronary arteries in the second to third wk of illness.
11 Giant coronary artery aneurysms (classic definition of >8 mm internal diameter) pose the greatest risk for rupture, thrombosis or stenosis, and myocardial infarction.
11
Previous studies have shown varying degrees of coronary involvement in Kawasaki disease ranging from 7-25% of untreated cases. 5, 12 In our study, we found 18(12%) patients were affected with coronary aneurysm, while 10 (6.6%) patients had perivascular brightness of coronary arteries. There was no giant aneurysm in our study. Although coronary artery sequelae are responsible for the major morbidity and mortality of KD, acute KD is often accompanied by noncoronary cardiac abnormalities, including left ventricular (LV) dysfunction, valvular regurgitation, pericardial effusion, and aortic root dilation. 13, 14 During acute KD, approximately 2% of patients will develop valvulitis, followed by scarring of the valve leaflets. 15 Mitral insufficiency is a serious complication of Kawasaki disease. During the acute phase of Kawasaki disease, mitral insufficiency may be secondary to active valvulitis, papillary muscle dysfunction or myocardial infarction16. In rare cases acute mitral regurgitation can be severe. 17 Mitral regurgitation was found in eight(5%) patients in our study. Kato et al 18 reported six patients (1.0% of their series) with mitral JCMS Nepal 2017;13(1):220-4 Echocardiographic evaluation of Kawasaki disease regurgitation in the acute or subacute stage of Kawasaki disease, with resolution in three patients, death from MI in two, and persistence from papillary muscle dysfunction in one. According to a study by Printz et al. 19 at least mild MR was noted in 27% of subjects on their baseline Echocardiogram and their findings was similar to the 23% reported cases of MR by Giddings et al. 20 but lower than the 47% reported by Suzuki et al. 21 These differences might be because different treatment eras were examined or because qualitative rather than quantitative definitions of MR were employed. 19 These lesions mostly disappear with the resolution of acute illness, 21 but a very small group of the lesions persist and progress. 22 Aortic regurgitation has been documented angiographically by Nakano et al 23 in 5% of children with Kawasaki disease and was attributed to valvulitis. Other investigators have observed a much lower incidence of aortic regurgitation in the acute phase 24 but late-onset aortic regurgitation has been reported as an exceedingly rare finding after Kawasaki disease and may be associated with the need for aortic valve replacement. 25 Aortic root dilation has also been noted in Kawasaki disease. 26 In our study, we found six patients (4%) had both aortic regurgitation and aortic root dilatation. According to a study by Printz et al. 19 aortic root dilation was present in 8% of their patients. Focus on the coronary aneurysms has diverted attention from other potential cardiovascular complications of KD like myocarditis. Diffuse myocarditis followed by myocardial fibrosis may lead to systolic or diastolic dysfunction in a subset of KD patients. 27, 28 Histologic evidence of myocarditis in the acute phase of Kawasaki disease is present in virtually all cases by endomyocardial biopsy 29 and in a majority of subjects when assessed by WBC-labeled radionuclide studies30. Myocarditis were found in 30% cases. The significant findings were global hypokinesia (LV Systolic dysfunction) with decreased ejection fraction.
In various studies myocardial inflammation has been documented in 50% to 70% of patients using 67Ga citrate scans (planar or single photon emission CT)31 and 99mTc-labeled white blood cell scans. 32 The severity of myocarditis does not appear to be associated with the risk of coronary artery aneurysms. 33, 34 Identification of pericardial effusion may also be a value in assessing risk of coronary artery changes. 20 In the acute phase of Kawasaki disease, pericardial inflammation can produce modest pericardial effusions. Although rarely of hemodynamic significance, there have been reports of pericardial tamponade in association with severe acute Kawasaki disease. 35, 36 We found pericardial effusion in significant number of patients; 18 out of 150 (12%) though majority of them had mild effusion. Belay ED et al. 37 
